Category
Fruquintinib
CAS Number
NA
Molecular Formula
C₂₀H₁₆N₂O₆
Molecular Weight
380.4 g/mol
Synonym

6-((6,7-dimethoxyquinazolin-4-yl)oxy)-2-methylbenzofuran-3-carboxylic acid ;

Keywords
Carboxylic Acids
Impurities Manufacturer in India
Impurities manufacturer and Suppliers in Hyderabad india
Slide_1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Fruquintinib Carboxylic Acid Impurity is a Fruquintinib-related impurity reference material with a Molecular Formula of C₂₀H₁₆N₂O₆, Molecular Weight of 380.40 g/mol, and CAS Number: Not Available (NA). Manasa Life Sciences, a pharmaceutical impurity reference standards manufacturer and supplier in India, offers this compound for Fruquintinib API impurity profiling, related substances identification, pharmaceutical analytical method development, impurity characterization, and quality control research. This Fruquintinib Carboxylic Acid Impurity Reference Standard supports analytical applications involving HPLC, UHPLC, LC-MS/MS, NMR spectroscopy, FTIR analysis, stability-indicating method validation, and anticancer drug impurity studies. 

As a supplier of Fruquintinib-related compounds, oncology API impurity standards, pharmaceutical degradation impurity reference materials, and analytical reference standards, Manasa Life Sciences serves API manufacturers, oncology pharmaceutical companies, CROs, CDMOs, and pharmaceutical research laboratories seeking reference materials for impurity analysis and pharmaceutical quality assessment. Product-specific analytical documentation, including Certificate of Analysis (COA), SDS/MSDS, chromatographic purity data, and spectral characterization reports, may be available upon request. Our pharmaceutical impurity reference materials support analytical research and testing activities aligned with applicable ICH Q3A, ICH Q3B, ICH Q2, USP, and EP guidelines, serving pharmaceutical industry requirements across India, UAE, GCC countries, Europe, Asia, and Africa.